A long-term study of bone mineral density in patients with phenylketonuria under diet therapy

Archives of Medical Science

Volumn 7, Issue 3, 2011, Pages 493-500

  Koura, Hala M ^a   Ismail, Nagwa Abdallah ^a   Kamel, Ashraf F ^a   Ahmed, Azza M ^a   Saad Hussein, Amal ^a   Effat, Laila K ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Bone mineral density; Diet; Osteoporosis; Phenylketonuria

Indexed keywords

PHENYLALANINE;

AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BODY MASS; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; MALE; PHENYLKETONURIA; SCHOOL CHILD;

EID: 79960472086     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.23417     Document Type: Article

References (34)

1. Kahler SG, Fahey MC. Metabolic disorders and mental retardation. Am J Med Genet 2003; 117: 31-41. (Pubitemid 37063629)
2. Allen JR, Humphries IR, Waters DL, et al. Decreased bone mineral density in children with phenylketonuria. Am J Clin Nutr 1994; 59: 419-22. (Pubitemid 24055911)
3. Shaw NJ. Osteoporosis in pediatrics. Arch Dis Child Educ Pract 2007; 92: 169-75.
4. Greeves LG, Carson DJ, Magee A, Patterson C. Fractures and phenylketonuria. Acta Paediatr 1997; 86: 242-4. (Pubitemid 27135268)
5. Al-Qadreh A, Schulpis KH, Athanasopoulou H, Men greli C, Skarpalezou A, Voskaki I. Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr 1998; 87: 1162-6.
6. Barat P, Barthe N, Redonnet-Vernhet I, Parrot F. The impact of the control of serum phenylalanine levels on osteopenia in patients with phenylketonuria. Eur J Pediatr 2002; 161: 687-8. (Pubitemid 35435545)
7. Carson DJ, Greeves LG, Sweeney LE, Crone MD. Osteopenia and phenylketonuria. Pediatr Radiol 1990; 20: 598-9. (Pubitemid 20322174)
8. Hillman L, Schlotzhauer C, Lee D, et al. Decreased bone mineralization in children with phenylketonuria under treatment. EurJ Pediatr 1996; 155 (Suppl I): S148-52.
9. McMurry MP, Chan GM, Leonard CO, Ernst SL. Related bone mineral status in children with phenylketonuriarelationship to nutritional intake and phenylalanine control. Am J Clin Nutr 1992; 55: 997-1004.
10. Pérez-Dueñas B, Cambra FJ, Vilaseca MA, Lambruschini N, Campistol J, Camacho JA. New approach to osteopenia in phenylketonuric patients. Acta Paediatr 2002; 91: 899-904.
11. Schwahn B, Mokov E, Scheidhauer K, Lettgen B, Schonau E. Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography. Acta Paediatr 1998; 87: 61-3. (Pubitemid 28086607)
12. Zeman J, Bayer M, Stepán J. Bone mineral density in patients with phenylketonuria. Acta Paediatr 1999; 88: 1348-51. (Pubitemid 30012556)
13. Modan-Moses D, Vered I, Schwartz G, et al. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 2007; 30: 202-8. (Pubitemid 46488002)
14. Virginia E. Schnett. Low protein cookery for phenylketonuria. 3rd ed. University of Wisconin 1997; 43-478.
15. Rutter M. Nature, nurture, and development: from evangelism through science toward policy and practice. Child Dev 2002; 73: 1-21. (Pubitemid 41693786)
16. Seidell JC, Doak CM, de Munter JS, Kuijper LD, Zonneveld C. Cross sectional growth references and implications for the development of an international growth standard for school-aged children and adolescents. Food Nutr Bull 2006; 27 (Suppl Growth Standard): S189-98.
17. Abd ElBaky A, Ismail N, Salama E, Abou-Zekri M, Fa touh A, Ragab R. Inappropriate restriction of dietary gluten and associated bone acquisition and bone density in Egyptian children with coeliac disease. Arch Med Sci 2009; 5: 589-95.
18. Ward LM, Glorieux FH. The spectrum of pediatric osteoporosis. In: Glorieux FH, Pettifor JM, Jüppner H (eds.). Pediatric bone: biology and diseases. San Diego, CA: Academic Press 2003; 401-42.
19. Cowell CT, Lu PW, Lloyd-Jones SA, et al. Volumetric bone mineral density - a potential role in paediatrics. Acta Pediatr Suppl 1995; 411: 12-6.
20. Przyrembel H, Bremer HJ. Nutrition, physical growth, and bone V density in treated phenylketonuria. EurJ Pediatr 2000; 159 (Suppl 2): S129-135.
21. Campistol J, Vilaseca MA, Cambra J, Lambruschini N. Diagnostico, tratamient o y seguimient o de las hiperfenilalaninemias. Act Nutr 1998; 24: 22-9.
22. Schulz B, Bremer HJ. Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Acta Pediatr 1995; 84: 743-8.
23. Aoki K, Ohwada M, Kitagawa TJ. Long-term follow-up study of patients with phenylketonuria detected by the newborn screening programme in Japan. Inherit Metab Dis 2007; 30: 608-13.
24. Dobbelaere D, Michaud L, Debrabander A, et al. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. J Inherit Metab Dis 2003; 26: 1-6.
25. Schafer F, Burgard P, Batzler U, et al. Growth and skeletal maturation in children with phenylketonuria. Acta Paediatr 1994; 83: 534-41. (Pubitemid 24184264)
26. Van der Schot LW, Doesburg WH, Sengers WCA. The phenylalanine response curve in relation to growth and mental development in the first years of life. Acta Paediatr 1994; 407: 68-9.
27. Verkerk PH, van Spronsen FJ, Smit GPA, Sengers RCA. Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. Arch Dis Child 1994; 71: 114-8. (Pubitemid 24261112)
28. Allen JR, Baur LA, Waters DL, et al. Body protein in prepubertal children with phenylketonuria. Eur J Clin Nutr 1996; 50: 178-86. (Pubitemid 26077887)
29. Dhondt JL, Largillière C, Moreno L, Farriaux JP. Physical growth in patients with phenylketonuria. 32nd Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Edinburgh (Abstract) 1994.
30. Acosta PB, Yannicelli S, Marriage B, et al. Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 1998; 27: 287-91. (Pubitemid 28430857)
31. Arnold GL, Vladutiu CJ, Kirby RS, Blakely EM, DeLuca JM. Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr 2002; 141: 243-6.
32. Yannicelli S, Ryan A. Improvements in behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine restricted diet: a national survey. J Inherit Metab Dis 1995; 18: 131-4.
33. Fitzgerald B, Morgan J, Keene N, Rollinson R, Hodgson A, Dalrymple-Smith J. An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability. J Intellect Disabil Res 2000; 44: 53-9. (Pubitemid 30076970)
34. Koch R, Moseley K, Ning J, Romstad A, Guldberg P, Guttler. Long-term beneficial effects of the phenylalaninerestricted diet in late-diagnosed individuals with phenylketonuria. Mol Genet Metab 1999; 67: 148-55.